ALIGNMENT HEALTHCARE INC (ALHC)
Health Care · Managed Healthcare · NASDAQ
Alignment Healthcare is a technology-driven Medicare Advantage provider leveraging its proprietary AVA platform to deliver coordinated, high-quality care to seniors.
What ALIGNMENT HEALTHCARE INC does
Alignment Healthcare is a technology-enabled Medicare Advantage insurance company that provides healthcare services to seniors. The company utilizes a proprietary technology platform, known as AVA, to manage member health data and coordinate care with a network of providers. Their business model focuses on improving member outcomes while controlling costs through proactive care management.
Themes: Medicare Advantage, senior healthcare, health insurance technology, care coordination
Fundamentals
- Price$13.16 as of 2026-08-21 close
- Market cap$2.7B as of 2026-08-21
- 1-year return-16.7% 2025-08-21 close $15.80 → 2026-08-21 close $13.16
- P/E68.60 as of 2026-08-24
- Net margin+0.9% as of 2026-08-24
- Gross margin+12.6% as of 2026-08-24
- ROE+20.0% as of 2026-08-24
- Debt / equity1.22 as of 2026-08-24
- Revenue growth (YoY)+37.2% as of 2026-08-24
- Revenue CAGR (3y)+40.2% SEC XBRL
- Beta1.10 as of 2026-08-24
- Last reported earnings2026-07-30 SEC EDGAR Form 8-K (Item 2.02)
How ALHC compares in its sector
- price-to-earnings ratiotop 25% 203 covered Health Care peers, as of 2026-08-24
- net profit marginmiddle range 504 covered Health Care peers, as of 2026-08-24
- operating marginmiddle range 504 covered Health Care peers, as of 2026-08-24
- gross marginbottom 10% 384 covered Health Care peers, as of 2026-08-24
- return on equitytop 25% 576 covered Health Care peers, as of 2026-08-24
- 3-year revenue CAGRtop 25% 402 covered Health Care peers
- free cash flow (absolute dollars, latest fiscal year)top 25% 493 covered Health Care peers, as of FY2025
Position among covered Health Care companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
Top 10 scores & list membership
ALHC is not currently in any published Top 10 list. Its scores are below.
Long-term score
Not scored for the long-term list: no shareholder return data.
Short-term score
26.2 #1673 of 1,704 scored · #235 of 240 in Health Care
Catalysts 42nd: the analyst consensus rating is unchanged since the prior reading; momentum 35th: mid-range on the stochastic oscillator; weakest is trend 8th: it is trading 29.8% below its 50-day average, the short-term trend line.
Scores as of 21 Aug 2026. Each bar is a percentile: how this company ranked against every company the score ranked, 0–100. A list is a published formula and its output, not a recommendation. Method version 2.
How ALIGNMENT HEALTHCARE INC looks technically
ALIGNMENT HEALTHCARE INC (ALHC) is trading 30.8% below its 200-day average, the long-term trend line — a long-term downtrend. Its 50-day average crossed below its 200-day average about 13 trading days ago — a "death cross", a bearish long-term signal. A strong downtrend is in place — ADX, a 0–100 trend-strength gauge, is 33, with sellers in control. Momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 33, neither overbought (above 70) nor oversold (below 30). MACD, a trend-momentum gauge, turned bullish about 1 trading day ago (its momentum flipped positive). It made a new 20-day low about 3 trading days ago. It is 3.6% above its 52-week low (its lowest price of the past year). Trading volume is unusually light — only about 42% of its 30-day average.
Trend
8
| Distance from the 200-day | it is trading 30.8% below its 200-day average, the long-term trend line — a long-term downtrend | -30.8% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $18.75 | $18.75 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $19.02 | $19.02 |
| Swing structure | each recent peak has been lower than the one before it and each dip deeper — the pattern chart-watchers call a downtrend, which describes where price has already been and not where it goes next | lower highs and lower lows |
| Last swing turn | its last significant turn was a swing low 21 calendar days ago — the swings before that are what the structure reading is measured on | 21 sessions |
| Wave structure | its recent swings can be read as a five-part downward sequence — what Elliott-wave chartists call an impulse — now in the fourth leg, a pullback against that downward direction; the labelling fails if price closes above 19.5. It is one of several labellings that fit, and it describes the swings already printed, not what comes next. The same swings also read as a completed three-part correction. | possible downward five-wave sequence, in wave 4 (one of several readings) |
| Since the 50/200 cross | its 50-day average crossed below its 200-day average about 13 trading days ago — a "death cross", a bearish long-term signal | 13 sessions |
| Trend strength (14-day ADX) | a strong downtrend is in place — ADX, a 0–100 trend-strength gauge, is 33, with sellers in control | 33.4 |
Momentum
3
| 14-day RSI | momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 33, neither overbought (above 70) nor oversold (below 30) | 33.5 |
|---|---|---|
| Position in its 14-day range | it is trading in the lower half of its 14-day range ($12.70 to $14.61) — its "stochastic" reading is 24 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been climbing within that range over the last few sessions. | 24.1 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, turned bullish about 1 trading day ago (its momentum flipped positive) | 1 session |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $25.12 | $25.12 |
|---|---|---|
| From the 52-week high | it is 47.6% below its 52-week high (its highest price of the past year) | -47.6% |
| Above the 52-week low | it is 3.6% above its 52-week low (its lowest price of the past year) | +3.6% |
| Below the 52-week high | it is 47.6% below its highest point of the past year | 47.6% |
| Since a 20-day breakout | it made a new 20-day low about 3 trading days ago | 3 sessions |
| Since a 55-day breakout | it made a new 55-day low about 3 trading days ago | 3 sessions |
| All-time high | its highest closing price on record is $28.59 (set on 2021-05-05) | $28.59 |
| Given back of the 52-week move | over the past year its closes ranged ($12.78 to $24.56), and it has recovered only a small part of its fall from last year’s high — 3% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $20.06 to $20.44. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 3.2% |
| From the all-time high | it is 54.0% below its all-time high | -54.0% |
| Nearest price level | it is trading 0.8% above a support level at $13.05 — a price it turned at four times since 2025-02-26, most recently on 2026-07-31. Since 2024-08-21 it has 3 such levels below the current price and 9 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | -0.8% |
| All-time low | its lowest closing price on record is $4.46 (set on 2024-04-03) | $4.46 |
| Above the all-time low | it is 195.1% above its all-time low | +195.1% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are unusually wide versus its own recent history (wider than about 83% of the past ~6 months) | 83rd percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $0.9368 between its high and its low — about 7.1% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $0.9368 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $10.56 and $18.63 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $10.56 – $14.59 – $18.63 |
| Typical daily range (% of price) | its price moves about 7.1% in a typical session — more volatile than most companies we cover. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 7.1% |
| Stretch from the 200-day average | it is trading 6.3 daily ranges below its 200-day average price (30.8% below it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 6.3 daily ranges below its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is unusually light — only about 42% of its 30-day average | 0.42× |
|---|
Analyst
2
| Change in the average price target | analysts' average price target is unchanged from the prior reading | 0.0% |
|---|---|---|
| Change in the consensus rating | the analyst consensus rating is unchanged since the prior reading | unchanged |
Candlestick patterns
1
| Since a bullish engulfing | 5 sessions ago it opened below the previous session's close and finished above that session's open — a "bullish engulfing" pair, where one up day more than undid the down day before it | 5 sessions ago |
|---|
Price gaps
3
| Gap at the open | it opened on 2026-08-21 1.1% above the previous session's close — an overnight gap, the part of the move that happened while the market was shut, and had not traded back through that level by the close | +1.1% |
|---|---|---|
| Open gap | it gapped 2.2% below the previous close 4 sessions ago and has not traded back through the level it left behind at 13.96 — an "unfilled gap", which describes a price range no trade has since crossed and is not a forecast that it will be crossed | -2.2% |
| Gap filled | a 2.0% gap down opened on 2026-08-03 has been "filled" 14 sessions ago — price traded back through the level the gap left behind, and it closed again during the very session that opened it | 14 sessions ago |
Price streaks
1
| Closing streak | it has closed higher 2 sessions in a row, a +2.97% move over the run — an unbroken run of up days, which describes what has already happened and says nothing about the next session | 2 sessions up |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock lagged the market by 41.1 percentage points (the stock lost 38.8% while the market gained 2.3%) | -41.1% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock lagged the market by 22.7 percentage points (the stock lost 19.6% while the market gained 3.1%) | -22.7% |
| vs market, 6 months | over the past 6 months this stock lagged the market by 47.2 percentage points (the stock lost 36.1% while the market gained 11.1%) | -47.2% |
| vs market, 12 months | over the past 12 months this stock lagged the market by 37.2 percentage points (the stock lost 16.7% while the market gained 20.5%) | -37.2% |
Signal agreement
2
| Bullish technical signals | 1 of the 9 technical signals we can compute for it is currently in a bullish state: MACD momentum is positive — these describe past price behaviour, not a forecast | 1 of 9 |
|---|---|---|
| Bearish technical signals | 6 of the 9 technical signals we can compute for it are currently in a bearish state: a strong downtrend, with sellers in control, a "death cross" — its 50-day average is below its 200-day, trading below its 200-day average, a fresh 20-day low, lagging the market over 6 months, trading below the Ichimoku cloud — these describe past price behaviour, not a forecast | 6 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading 31% below the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-07-15 and projected forward over today's price, the side traders read as an established downtrend, with the band above acting as the level that would have to be cleared. The band itself is thick, spanning 16.0% of the share price, which is taken to mean a barrier that has held for a while and takes effort to cross. | -31.1% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is 30% below the average price paid so far this year, so the typical buyer over that stretch is under water. That average is $18.72 — a volume-weighted average of daily closes over 159 sessions, not a true tick-by-tick VWAP. | -29.7% |
|---|---|---|
| Vs the average paid since it last reported | the price is 6% below the average price paid since it last reported on 2026-07-30 (its 10-Q), so the typical buyer over that stretch is under water. That average is $14.04 — a volume-weighted average of daily closes over 17 sessions, not a true tick-by-tick VWAP. | -6.2% |
Price levels it has turned at before
ALHC last closed at $13.16 on 2026-08-21. Since 2024-08-21 it has turned at 3 prices below its last close and 9 above; the 3 nearest below and the 3 nearest above are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $13.05 | Support | 0.8% below the last close | turned there four times · 2025-02-26 to 2026-07-31 |
| $12.30 | Support | 6.5% below the last close | turned there twice · 2024-09-13 to 2024-10-08 |
| $14.22 | Resistance | 8.1% above the last close | turned there three times · 2024-11-06 to 2025-07-01 |
| $15.81 | Resistance | 20.1% above the last close | turned there 7 times · 2025-01-28 to 2026-05-15 |
| $10.14 | Support | 22.9% below the last close | turned there twice · 2024-10-23 to 2024-12-20 |
| $16.29 | Resistance | 23.8% above the last close | turned there four times · 2025-03-03 to 2026-03-27 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
Its recent swings can be read as a five-part downward sequence — what Elliott-wave chartists call an impulse — now in leg 4 of five, a pullback against that direction.
This labelling fails — stops being a possible reading at all — if it closes above $19.50.
This is one of several labellings that fit the same swings, so treat it as a reading rather than the reading. It was chosen from 2 labellings that survived the rules, counting shorter readings of the same bars.
On past moves of this shape the leg has usually ended somewhere between $15.18 and $17.46 — that is where it has tended to end if the count holds, not a forecast of where the price goes.
Alternate reading: The same swings also read as a completed three-part correction, which fails on a close below $13.13.
This reading has stood for 1 trading day, since 2026-08-21.
Read from daily closes as of 2026-08-21.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading below the 200-day moving average · Recent death cross (50-day crossed below 200-day) · Pulled back from the 12-month high · Broke down to a new 20-day low · MACD just crossed bullish (12/26/9) · lagging the market | Learn: moving average · golden cross · adx · rsi · macd · breakout · fifty two week high low · volume and relative volume
Based on daily closing prices as of 2026-08-21. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Consensus ratingStrong Buy (1.50 mean, 1=Strong Buy…5=Strong Sell) — 13 analysts
- Mean price target$24.08 range $16.00 – $30.00; median $25.00
Analyst estimates, as of 2026-08-24. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Analyst EPS estimate for ALHC
- Consensus EPS estimate$0.06 next reporting period, as of 2026-08-24
Change over time is not available yet: it needs two readings of the same reporting period at least 30 days apart, and we have been recording these estimates since 2026-08-04. An estimate for a DIFFERENT quarter is not a revision, so a reading from before the last report is never compared with one after it.
The consensus estimate for the next reporting period, and how it has moved between readings of that SAME period. A change is measured only between readings estimating one period — when a company reports, the consensus moves to the next quarter and the two numbers are not comparable. Informational only, not a forecast and not advice.
Key risks (from latest filing)
["Heavy dependence on CMS reimbursements and government health policy changes.","Ability to maintain high Five Star Quality Rating System scores.","Risk of inaccurate estimation of medical expenses and member risk adjustment scores."]
What changed in the latest 10-Q
AI-assisted comparison of ALHC's 10-Q filed 2026-04-30 against the prior one filed 2025-10-30.
Management's Discussion & Analysis (MD&A)
- Added:
- Newer filing (2026-04-30): 'Our unique clinical model, led by employed clinical teams known as Care Anywhere, acts upon insights derived from our proprietary technology platform, AVA. This integration between our technology and employed care model is a key element of our business with capabilities that we expect to impact our future performance.' - expanded description of Care Anywhere model in 'Factors Affecting Our Performance' section
- Newer filing (2026-04-30): Reference to 'Annual Report on Form 10-K for the year ended December 31, 2025' versus older reference to year ended December 31, 2024
- Removed:
- Older filing (2025-10-30): 'Our model is based on a flywheel concept, referred to as our "virtuous cycle," which is designed to delight our senior consumers...' - entire 'virtuous cycle' paragraph removed from newer filing
- Reworded:
- Description of Alignment changed from 'consumer-centric platform' (older) to 'consumer-centric and clinically focused platform' (newer)
- Health Plan Membership reference changed from 'the "Alignment Health Plans"' (older) to 'the "Alignment Health Plan"' (newer) - singular vs. plural
- Membership count updated from '229,600 as of September 30, 2025' (older) to '284,800 members as of March 31, 2026' (newer)
- Market share data updated from '5% market share' as of September 30, 2025 (older) to '6% market share' as of March 31, 2026 (newer)
- Plan year reference changed from '2025 plan year' (older) to '2026 plan year' (newer)
- Medicare-eligible seniors in markets updated from 'approximately 8.3 million' (older) to 'approximately 8.4 million' (newer)
- CMS Star Ratings example year changed from 'CMS's announcement of the 2025 Ratings occurred in the second half of 2024 and will impact our financial performance in 2026' (older) to 'CMS's announcement of the 2026 Ratings occurred in the second half of 2025 and will impact our financial performance in 2027' (newer)
- AVA description restructured - older filing described AVA separately; newer filing integrated AVA description with Care Anywhere model description in opening sentences of 'Factors Affecting Our Performance'
- Notes:
- The newer filing text appears to be truncated mid-sentence at 'Achieve Superior Unit Economics' section, limiting full comparison of that section
- The older filing text also appears truncated in the 'Effectively Manage the Quality of Care' section, making complete comparison of that section impossible
Risk Factors
- Added:
- Added risk factor: 'the impact on our business of cybersecurity breaches, loss of data or other disruptions causing the compromise of sensitive information or preventing us from accessing critical information' (2026-04-30 filing)
- Added risk factor: 'the cost and other potential adverse impacts of legal proceedings and litigation, including intellectual property and privacy disputes' (2026-04-30 filing)
- Added risk factor: 'the potential impact of certain affirmative and negative covenants in our credit agreement on our business' as part of indebtedness risk (2026-04-30 filing)
- Removed:
- Removed risk factor: 'the effect of our relatively limited operating history on investors' ability to evaluate our current business and future prospects' (2025-10-30 filing)
- Removed risk factor: 'our management team's limited experience managing a public company' (2025-10-30 filing)
- Removed risk factor: 'the potential adverse impact of claims by third parties that we are infringing on, misappropriating or otherwise violating their intellectual property rights' (2025-10-30 filing)
- Reworded:
- Changed 'our ability to maintain a high rating for our health plans on the Five Star Quality Rating System' to 'our ability to maintain a high rating for our plans on the Five Star Quality Rating System' (2026-04-30 filing)
- Changed 'our ability to develop and maintain satisfactory relationships with care providers who service our members' to 'our ability to develop and maintain satisfactory relationships with care providers that service our members' (2026-04-30 filing)
- Changed 'the impact on our business of security breaches, loss of data or other disruptions' to 'the impact on our business of cybersecurity breaches, loss of data or other disruptions' (2026-04-30 filing)
- Changed 'the cost of legal proceedings and litigation, including intellectual property and privacy disputes' to 'the cost and other potential adverse impacts of legal proceedings and litigation, including intellectual property and privacy disputes' (2026-04-30 filing)
- Changed 'our ability to generate sufficient cash flow to service all of our indebtedness' to 'our ability to generate sufficient cash flow to service all of our indebtedness and the potential impact of certain affirmative and negative covenants in our credit agreement on our business' (2026-04-30 filing)
- Notes:
- Page numbers differ between filings (38 vs 42 for Risk Factors section), reflecting different overall document lengths
- Comparison is limited to the Forward-Looking Statements section and visible risk factors list; full Risk Factors section content not provided in source texts
AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.
Insider activity (SEC Form 4)
1 open-market purchase and 13 open-market sales by insiders in the last 90 days.
- Last 30 days0 buys · 2 sells ($4M) — 2 selling insiders
- Last 90 days1 buy ($197627) · 13 sells ($23M) — 1 buying, 4 selling insiders
- Last 180 days1 buy ($197627) · 23 sells ($41M) — 1 buying, 5 selling insiders
Activity heuristic: net selling (a transparent product heuristic from the counts above, not a prediction or advice)
Most recent open-market transaction: 2026-08-14. As of 2026-08-24.
View full insider trading history → View SEC Form 3/4/5 filingsAsk about ALHC's insider activity →
Only open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
Institutional ownership (13F)
5 institutional 13F filers reported holding ALHC as of 2026-03-31 (quarter-end position, filed within 45 days).
- Distinct 13F filers 5
- Reported shares held 42,738,821
- Reported value $753,058,031
reported quarterly holdings change (2025-12-31 → 2026-03-31): 0 new, 5 increased, 0 decreased, 0 exited. Change counts cover only managers that filed 13F reports in BOTH quarters, derived between two quarter-end snapshots — not same-day trades; a single manager is never said to have "bought" or "sold".
Institutional holdings are quarter-end long positions reported on SEC Form 13F-HR, filed up to 45 days after the quarter ends — they are delayed, are not real-time trades, exclude short positions and most non-US securities, and are not investment advice. Any increase/decrease is a reported change between two quarterly snapshots, not a same-day purchase or sale. These are quarter-end snapshots from the 13F filings on SEC EDGAR, filed within 45 days — not real-time, and any change is a difference between two quarterly reports, not a same-day trade. Informational only — not financial advice.
Short interest (FINRA)
ALHC had 22,045,849 shares of reported short interest as of the 2026-07-31 FINRA settlement date (delayed, bi-monthly; not real-time).
ALHC had 10.6% of its shares outstanding sold short as of the 2026-07-31 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 4.61 days to cover at the same settlement.
- Reported short interest (shares) 22,045,849
- Short interest (% of shares outstanding) 10.6%
- Prior settlement (shares) 24,812,050
- Reported change -11.15%
- Days to cover (reported) 4.61
Reported to FINRA as of the 2026-07-31 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- UnitedHealth Group (UNH)
- Humana (HUM)
- CVS Health (CVS)
- Elevance Health (ELV)
- Cigna Group (CI)
- Centene (CNC)
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare ALHC vs…
Frequently asked questions
What does ALIGNMENT HEALTHCARE INC (ALHC) do?
Alignment Healthcare is a technology-enabled Medicare Advantage insurance company that provides healthcare services to seniors. The company utilizes a proprietary technology platform, known as AVA, to manage member health data and coordinate care with a network of providers. Their business model focuses on improving member outcomes while controlling costs through proactive care management.
What sector is ALIGNMENT HEALTHCARE INC (ALHC) in?
ALIGNMENT HEALTHCARE INC (ALHC) is classified in the Health Care sector. Its industry is Managed Healthcare. It trades on NASDAQ.
Who are ALIGNMENT HEALTHCARE INC's (ALHC) competitors?
Notable peers of ALIGNMENT HEALTHCARE INC (ALHC) include UnitedHealth Group, Humana, CVS Health, Elevance Health and Cigna Group. This peer set is informational only — not financial advice.
Is ALIGNMENT HEALTHCARE INC (ALHC) overbought or oversold right now?
ALIGNMENT HEALTHCARE INC (ALHC) is currently neither overbought nor oversold — its 14-day RSI (a 0–100 momentum gauge) is 33, in the neutral middle (as of 2026-08-21). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on ALHC come from?
Fundamentals and prices come from market data, as of 2026-08-24; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: market data, as of 2026-08-24. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-21.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.